Haemonetics (HAE) Stock Price Target 2026

The average analyst price target for Haemonetics is $116, 1.9% below the current price. Of 11 analysts, 9 rate it Buy and 2 Hold. Targets range from $74 to $149. The latest change came on Nov 6, 2026, when Citigroup raised its price target on Haemonetics from $123 to $149 and kept a Buy rating.

The Average Analyst Price Target for Haemonetics is $116.

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

8Buy

2Hold

Consensus RatingOutperform# Analysts11Avg. Consensus PT$116Upside to Avg. PT-1.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Haemonetics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$123→$149
Nov 6, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$140→$145
Nov 5, 2026	BTIG	Marie Thibault	PT Raise	Buy	$130→$142
Oct 9, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$118→$140
Oct 9, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$95→$140
Oct 8, 2026	BTIG	Marie Thibault	PT Raise	Buy	$110→$130
Sep 17, 2026	Citigroup	Joanne Wuensch	Upgrade	Neutral→Buy	$92→$123
Sep 3, 2026	Raymond James	Andrew Cooper	PT Raise	Outperform	$105→$125
Aug 21, 2026	Baird	David Rescott	PT Raise	Outperform	$96→$119
Aug 19, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$95→$118
Aug 18, 2026	BTIG	Marie Thibault	PT Raise	Buy	$96→$110
Aug 7, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$79→$92
Aug 7, 2026	JP Morgan	Allen Gong	PT Raise	Neutral	$62→$86
Aug 6, 2026	BTIG	Marie Thibault	PT Raise	Buy	$84→$96
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90
Jun 26, 2026	BTIG	Marie Thibault	Maintained	Buy	$84
Jun 17, 2026	BTIG	Marie Thibault	Maintained	Buy	$84
Jun 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$70→$85
May 28, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$64→$70
May 22, 2026	B of A Securities	Craig Bijou	Upgrade	Neutral→Buy	$72→$80